In vitro release, rheological, and stability studies of mefenamic acid coprecipitates in topical formulations

Pharmaceutical Development and Technology

Volumn 16, Issue 5, 2011, Pages 497-510

  Ahmed, Tarek A ^a   Ibrahim, Hany M ^a   Ibrahim, Fathy ^a   Samy, Ahmed M ^a   Fetoh, Ehab ^a   Nutan, Mohammad T H ^b  

^a Al Azhar University   (Egypt)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Coprecipitates; Gel; Mefenamic acid; Methylcellulose; PVP K90; Topical

Indexed keywords

CARBOPOL 934; CARBOPOL 940; CARBOXYMETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL 2000; MACROGOL 4000; MACROGOL 6000; MANNITOL; MEFENAMIC ACID; METHYLCELLULOSE; POLOXAMER; POLYMER; POVIDONE; UREA;

ARTICLE; CREAM; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG BIOAVAILABILITY; DRUG CONCENTRATION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; FLOW KINETICS; GEL; IN VITRO STUDY; INFRARED SPECTROSCOPY; OINTMENT; PH; PHYSICAL CHEMISTRY; PLASTICITY; PRIORITY JOURNAL; THIXOTROPY; VISCOSITY; X RAY DIFFRACTION;

ABSORPTION; ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; GELS; HUMANS; MEFENAMIC ACID; METHYLCELLULOSE; OINTMENT BASES; OINTMENTS; POLYETHYLENES; POLYPROPYLENES; POLYVINYLS; PYRROLIDINES; RHEOLOGY; VISCOSITY;

EID: 80052886665     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2010.495394     Document Type: Article

References (35)

1. Brooks PM, Day RO. Non-steroidal anti-infammatory drugs differences and similarities. N Engl J Med 1991;324:1716-1725.
2. Smolinske SC, Hall AH, Vandenberg SA, Spoerke DG, McBride PV. Toxic efects of non-steroidal anti-infammatory drugs in overdose: An overview of recent evidence on clinical efects and dose response relationships. Drug Saf 1990;5:252-274. (Pubitemid 20294970)
3. Loth H. Vehicular infuence on transdermal drug penetration. Int J Pharm 1991;68:1-10.
4. TenHoor CN, Bakatselou V, Dressman J. Solubility of Mefenamic acid under simulated fed-and fasted state conditions. Pharm Res 1991;8:1203-1205.
5. Naito S-I, Nakamori S, Awataguchi M, Nakajima T, Tominaga H. Observations on and pharmacokinetic discussion of percutaneous absorption of mefenamic acid. Int J Pharm 1985;24:127-147. (Pubitemid 15062524)
6. Schwenker G, Chen JB. 1,2-Dihydro-3,1-benzoxazin-4-one and 4H-1,2-dihydro-pyrido-[2,3-d]-[1,3]-oxazin-4-one derivatives as potential prodrugs. Part III: Permeability through excised human skin in vitro. Arch Pharm (Weinheim) 1991;324:891-894.
7. Taub ME, Kristensen L, Frokjaer S. Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I-IV. Eur J Pharm Sci 2002;15:331-340. (Pubitemid 34436920)
8. Chiou WL, Smith LD. Solid dispersion approach to the formulation of organic liquid drugs using polyethylene glycol 6000 as a carrier. J Pharm Sci 1971;60:125-127.
9. Takeuchi H, Nagira S, Yamamoto H, Kawashima Y. Solid dispersion particles of tolbutamide prepared with fne silica particles by the spray-drying method. Powder Technol 2004;141:187-195. (Pubitemid 38726136)
10. Asada M, Takahashi H, Okamoto H, Tanino H, Danjo K. Teophylline particle design using chitosan by the spray drying. Int J Pharm 2004;270:167-174. (Pubitemid 38077097)
11. Habib MJ. Pharmaceutical solid dispersion technology. 1st ed. Lancaster, PA: Informa Healthcare; 2000.
12. Nishihata T, Kamada A, Sakai K, Takahashi K, Matsumoto K, Shinozaki K, Tabata Y, Keigami M, Miyagi T, Tatsumi N. Percutaneous absorption of diclofenac in rats and humans: Aqueous gel formulation. Int J Pharm 1988;46:1-7
13. USP, the United States Pharmacopoeia. 27th ed. Rockville, MD: Pharmacopoeial Convention Inc; 2004.
14. Block LH. Medicated topicals. In: Remington: Te science and practice of pharmacy. 21st ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:871-888.
15. Gallardo V, Zouaki Y, Parera A, Ruiz MA. Efect of cellulosic polymer on the release of salicylates in topical formulations. React Funct Polym 2001;50:33-40. (Pubitemid 33711072)
16. Buckton G, Tawburic S. Drug release from gel bases: A case for enthalpy-entropy compensation. J Control Release 1992;20:29-35.
17. Sinko PJ. Martin's physical pharmacy and pharmaceutical sciences. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.
18. Tas Ç, Özkan Y, Savaser A, Baykara T. In vitro release studies of chlorpheniramine maleate from gels prepared by diferent cellulose derivatives. Il Farmaco 2003;58:605-611. (Pubitemid 36870834)
19. Fujii M, Okada H, Shibata Y, Teramachi H, Kondoh M, Watanabe Y. Preparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidone. Int J Pharm 2005;293:145-153. (Pubitemid 40381088)
20. Shibata Y, Fujii M, Kokudai M, Noda S, Okada H, Kondoh M, Watanabe Y. Efect of characteristics of compounds on maintenance of an amorphous state in solid dispersion with crospovi-done. J Pharm Sci 2007;96:1537-1547. (Pubitemid 46953769)
21. Dong Z, Chatterji A, Sandhu H, Choi DS, Chokshi H, Shah N. Evaluation of solid state properties of solid dispersions prepared by hot-melt extrusion and solvent co-precipitation. Int J Pharm 2008;355:141-149.
22. Pavia DL, Lampman GM, Kriz GS, Vyvyan JA. Introduction to spectroscopy. 4th ed. Independence, KY: Brooks/Cole; 2008.
23. Taylor LS, Zograf G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res 1997;14:1691-1698. (Pubitemid 28062912)
24. Watanabe T, Hasegawa S, Wakiyama N, Kusai A, Senna M. Comparison between polyvinyl pyrrolidone and silica nanopar-ticles as carriers for indomethacin in a solid state dispersion. Int J Pharm 2003;250:283-286. (Pubitemid 35447957)
25. Shibata Y, Fujii M, Sugamura Y, Yoshikawa R, Fujimoto S, Nakanishi S, Motosugi Y, Koizumi N, Yamada M, Ouchi K, Watanabe Y. Te preparation of a solid dispersion powder of indomethacin with crospovidone using a twin-screw extruder or kneader. Int J Pharm 2008;365:53-60.
26. Verheyen S, Blaton N, Kinget R, Van den Mooter G. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int J Pharm 2002;249:45-58. (Pubitemid 35333431)
27. ® E100. Eur J Pharm Biopharm 2008;70:861-868.
28. Delneuville I, Dechesne JP, Delattre L. Preparation and study of the characteristics of dithranol:polyvinyl pyrrolidone coevapo-rates. Int J Pharm 1998;168:109-118. (Pubitemid 28293669)
29. Fang L, Numajiri S, Kobayashi D, Morimoto Y. Te use of complexation with alkanolamines to facilitate skin permeation of mefenamic acid. Int J Pharm 2003;262:13-22. (Pubitemid 36966689)
30. Ozsoy Y, Güngör S, Cevher E. Vehicle efects on in vitro release of tiaprofenic acid from diferent topical formulations. Il Farmaco 2004;59:563-566. (Pubitemid 38844814)
31. Fang JY, Sung KC, Hu OY, Chen HY. Transdermal delivery of nalbuphine and nalbuphine pivalate from hydrogels by passive difusions and iontophoresis. Arzneimittel-Forschung 2001;51:408-413. (Pubitemid 32452808)
32. Wang YY, Hong CT, Chiu W T, Fang JY. In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels. Int J Pharm 2001;224:89-104.
33. Osborne DV, Amann AH. Topical drug delivery formulations. Vol. 42. New York: Marcel Dekker; 1990.
34. Al-Khamis KI, Davis SS, Hadgraft J. Microviscosity and drug release from topical gel formulations. Pharm Res 1986;3:214-217. (Pubitemid 17195372)
35. Mohammed FA. Topical permeation characteristics of diclofenac sodium from NaCMC gels in comparison with conventional gel formulations. Drug Dev Ind Pharm 2001;27:1083-1097. (Pubitemid 34053204)